1st International Consensus Conference
"Reduction in Mortality in Cardiac Anesthesia and Intensive Care"

Please agree or disagree with the following topics/statements/papers. You can still influence the final results of the consensus conference but you HAVE TO support your opinion with published evidence of statistically significant reduction/increase in mortality in cardiac anesthesia / intensive care.

Drugs/Techniques that can/might reduce mortality

B blockers

Scientific evidence: non-RCT
Effect on mortality: reduction
Data from a large cohort study suggest that pre-operative beta blockers reduce mortality in CABG patients without severe (EF<30%) LV dysfunction. Therefore beta blockers should not be discontinued prior to CABG.
I agree
I disagree
I don't know
comments

Early aspirin after CABG

Scientific evidence: non-RCT
Effect on mortality: reduction
Early (6-48h) use of aspirin after CABG unless specifically contraindicated is safe and is associated with a reduction in mortality. The evidence comes from a non RCT.
I agree
I disagree
I don't know
comments

High-Volume Surgeon

Scientific evidence: non-RCT
Effect on mortality: reduction
Operative mortality in cardiac surgery appears to be related to surgeon volume.
I agree
I disagree
I don't know
comments

Insuline (postoperatively)

Scientific evidence: RCT
Effect on mortality: reduction
A single centre randomized study demonstrated that maintaining a tight glycemic control with continuous insulin infusion can reduce mortality in critically ill patients, including post-cardiac surgery patients. However, subsequent evidence pointed out that aiming at an excessive tight glycemic control could potentially increase hypoglycemic episodes and mortality.
I agree
I disagree
I don't know
comments

Intra Aortic Balloon Pump (IABP)

Scientific evidence: meta-analysis of RCTs
Effect on mortality: reduction
Pre-operative IABP might reduce mortality in elective high risk patients undergoing CABG unless specifically contraindicated.
I agree
I disagree
I don't know
comments

Levosimendan

Scientific evidence: meta-analysis of RCTs
Effect on mortality: reduction
In a meta-analysis of pooled pre- and post-operative administration, Levosimendan seems to reduce mortality. However, there is not enough evidence to recommend its routine administration since statistical significance is lost when data are evaluated separately. Caution is advised in bolus administration.
I agree
I disagree
I don't know
comments

Pexelizumab

Scientific evidence: meta-analysis of RCTs
Effect on mortality: reduction
Pexelizumab might reduce mortality in patients undergoing CABG. These findings come from a subgroup of a meta-analysis of RCTs and need further evaluation.
I agree
I disagree
I don't know
comments

Statins

Scientific evidence: meta-analysis of RCT and non-RCTs
Effect on mortality: reduction
A meta-analysis of mostly non-RCTs in CABG suggested a reduction of mortality in patients receiving pre-operative statins. This topic merits further investigation.
I agree
I disagree
I don't know
comments

Volatile anesthetics

Scientific evidence: meta-analysis of RCTs
Effect on mortality: reduction
Volatile anaesthetics can reduce 30-day mortality in hemodinamically stable patients undergoing CABG, as documented by a meta-analysis of RCTs.
I agree
I disagree
I don't know
comments

Drugs/Techniques that can/might increase mortality

Aprotinin

Scientific evidence: RCT
Effect on mortality: increase
Despite the possibility of a modest reduction in massive bleeding, aprotinin increases mortality in high risk patients undergoing CCH.
I agree
I disagree
I don't know
comments

Old (>15days) red blood cells transfusions

Scientific evidence: Non-RCT
Effect on mortality: increase
A large non-RCT suggests that transfusion of packed red blood cells stored for more than 15 days is associated with an increase of short and long term mortality.
I agree
I disagree
I don't know
comments